Applications of the microphysiology systems database for experimental ADME-Tox and disease models† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c9lc01047e

To accelerate the development and application of Microphysiological Systems (MPS) in biomedical research and drug discovery/development, a centralized resource is required to provide the detailed design, application, and performance data that enables industry and research scientists to select, optimize, and/or develop new MPS solutions, as well as to harness data from MPS models. We have previously implemented an open source Microphysiology Systems Database (MPS-Db), with a simple icon driven interface, as a resource for MPS researchers and drug discovery/development scientists (https://mps.csb.pitt.edu). The MPS-Db captures and aggregates data from MPS, ranging from static microplate models to integrated, multi-organ microfluidic models, and associates those data with reference data from chemical, biochemical, pre-clinical, clinical and post-marketing sources to support the design, development, validation, application and interpretation of the models. The MPS-Db enables users to manage their multifactor, multichip studies, then upload, analyze, review, computationally model and share data. Here we discuss how the sharing of MPS study data in the MS-Db is under user control and can be kept private to the individual user, shared with a select group of collaborators, or be made accessible to the general scientific community. We also present a test case using our liver acinus MPS model (LAMPS) as an example and discuss the use of the MPS-Db in managing, designing, and analyzing MPS study data, assessing the reproducibility of MPS models, and evaluating the concordance of MPS model results with clinical findings. We introduce the Disease Portal module with links to resources for the design of MPS disease models and studies and discuss the integration of computational models for the prediction of PK/PD and disease pathways using data generated from MPS models.

[1]  Kevin Barraclough,et al.  I and i , 2001, BMJ : British Medical Journal.

[2]  M. Malcangio,et al.  The role of glia in the spinal cord in neuropathic and inflammatory pain. , 2015, Handbook of experimental pharmacology.

[3]  D. Tagle,et al.  Microphysiological Systems (“Organs‐on‐Chips”) for Drug Efficacy and Toxicity Testing , 2017, Clinical and translational science.

[4]  John P. A. Ioannidis,et al.  What does research reproducibility mean? , 2016, Science Translational Medicine.

[5]  K. McGraw,et al.  Forming inferences about some intraclass correlation coefficients. , 1996 .

[6]  Sunghee E. Park,et al.  Organoids-on-a-chip , 2019, Science.

[7]  L. Studer,et al.  When rejuvenation is a problem: challenges of modeling late-onset neurodegenerative disease , 2015, Development.

[8]  D. L. Taylor,et al.  Fluorescent protein biosensors applied to microphysiological systems , 2015, Experimental biology and medicine.

[9]  N. Davies,et al.  Clinical Pharmacokinetics of Diclofenac , 1997, Clinical pharmacokinetics.

[10]  Aaas News,et al.  Book Reviews , 1893, Buffalo Medical and Surgical Journal.

[11]  Gordana Vunjak-Novakovic,et al.  Organs-on-a-Chip: A Fast Track for Engineered Human Tissues in Drug Development. , 2018, Cell stem cell.

[12]  Albert Gough,et al.  Corrigendum: Functional Coupling of Human Microphysiology Systems: Intestine, Liver, Kidney Proximal Tubule, Blood-Brain Barrier and Skeletal Muscle , 2017, Scientific Reports.

[13]  Aarathi Balijepalli,et al.  Organs-on-chips: research and commercial perspectives. , 2017, Drug discovery today.

[14]  M. Ghert,et al.  Lost in translation: animal models and clinical trials in cancer treatment. , 2014, American journal of translational research.

[15]  J. Serrano,et al.  LiverTox: A website on drug‐induced liver injury , 2013, Hepatology.

[16]  D. L. Taylor,et al.  A glass-based, continuously zonated and vascularized human liver acinus microphysiological system (vLAMPS) designed for experimental modeling of diseases and ADME/TOX. , 2018, Lab on a chip.

[17]  Terry K Koo,et al.  A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research. , 2016, Journal of chiropractic medicine.

[18]  M. Rolfe,et al.  Mouse models of cystic fibrosis. , 2001, Trends in genetics : TIG.

[19]  Anup D. Sharma,et al.  Control of oxygen tension recapitulates zone-specific functions in human liver microphysiology systems , 2017, Experimental biology and medicine.

[20]  K. Lee,et al.  Pitfalls and Important Issues in Testing Reliability Using Intraclass Correlation Coefficients in Orthopaedic Research , 2012, Clinics in orthopedic surgery.

[21]  Daniel E. Lefever,et al.  Harnessing Human Microphysiology Systems as Key Experimental Models for Quantitative Systems Pharmacology. , 2019, Handbook of experimental pharmacology.

[22]  Nina Isoherranen,et al.  Emerging Role of Organ‐on‐a‐Chip Technologies in Quantitative Clinical Pharmacology Evaluation , 2019, Clinical and translational science.

[23]  R. Stephenson A and V , 1962, The British journal of ophthalmology.

[24]  T. Baillie,et al.  Roles of human hepatic cytochrome P450s 2C9 and 3A4 in the metabolic activation of diclofenac. , 1999, Chemical research in toxicology.

[25]  Yasuyuki Sakai,et al.  Technical aspects of microphysiological systems (MPS) as a promising wet human-in-vivo simulator. , 2017, Drug metabolism and pharmacokinetics.

[26]  Franco Lombardo,et al.  Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics. , 2004, Journal of medicinal chemistry.

[27]  W. Marsden I and J , 2012 .

[28]  Zhongze Gu,et al.  Organ-on-a-Chip Systems: Microengineering to Biomimic Living Systems. , 2016, Small.

[29]  J. Fleiss,et al.  Intraclass correlations: uses in assessing rater reliability. , 1979, Psychological bulletin.

[30]  GoughAlbert,et al.  The Microphysiology Systems Database for Analyzing and Modeling Compound Interactions with Human and Animal Organ Models. , 2016 .

[31]  Philip Wexler,et al.  Toxnet: A computerized collection of toxicological and environmental health information , 2000, Toxicology and industrial health.

[32]  P. Sinko,et al.  Estimating Human Drug Oral Absorption Kinetics from Caco-2 Permeability Using an Absorption-Disposition Model: Model Development and Evaluation and Derivation of Analytical Solutions for ka and Fa , 2005, Journal of Pharmacology and Experimental Therapeutics.

[33]  Vijaya L. Melnick,et al.  Alzheimer’s Dementia , 1985, Contemporary Issues in Biomedicine, Ethics, and Society.

[34]  HighWire Press,et al.  Drug metabolism and disposition : the biological fate of chemicals. , 1973 .

[35]  A. Sanyal,et al.  Preclinical models of non-alcoholic fatty liver disease. , 2018, Journal of hepatology.

[36]  J. Luyendyk,et al.  Role of hemostatic factors in hepatic injury and disease: animal models de‐liver , 2016, Journal of thrombosis and haemostasis : JTH.

[37]  S. Strom,et al.  Ritonavir and Efavirenz Significantly Alter the Metabolism of Erlotinib—an Observation in Primary Cultures of Human Hepatocytes That Is Relevant to HIV Patients with Cancer , 2013, Drug Metabolism and Disposition.

[38]  D. L. Taylor,et al.  Modeling the Effect of the Metastatic Microenvironment on Phenotypes Conferred by Estrogen Receptor Mutations Using a Human Liver Microphysiological System , 2019, Scientific Reports.

[39]  John P A Ioannidis,et al.  Improving Validation Practices in “Omics” Research , 2011, Science.

[40]  G. Glass Primary, Secondary, and Meta-Analysis of Research1 , 1976 .

[41]  R. Trevethan,et al.  Intraclass correlation coefficients: clearing the air, extending some cautions, and making some requests , 2017, Health Services and Outcomes Research Methodology.

[42]  Jacob Cohen Statistical Power Analysis for the Behavioral Sciences , 1969, The SAGE Encyclopedia of Research Design.

[43]  L A Low,et al.  Tissue chips - innovative tools for drug development and disease modeling. , 2017, Lab on a chip.

[44]  Albert Gough,et al.  A human liver microphysiology platform for investigating physiology, drug safety, and disease models , 2016, Experimental biology and medicine.

[45]  M. Haddrick,et al.  Organ-on-a-chip technology: turning its potential for clinical benefit into reality. , 2019, Drug discovery today.